+1-800-337-8212

Follow us

Facebook Twitter Linkedin
LOGIN

Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines. The Phase 1-ready asset was licensed from China-based DartsBio Pharmaceuticals.

The post Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic appeared first on MedCity News.

Leave a Replay

Facebook-f Twitter Youtube

Related Posts

Follow Us

Sign up for our Newsletter

HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.

Our Company

Resources

Connect

Facebook-f Twitter

Contact Us